There are 2789 resources available
The value of genomics information for trial design
Presenter: Edwin Cuppen
Session: Biology-guided combination cancer therapy
Resources:
Slides
Webcast
Combining radiotherapy and DNA repair inhibition
Presenter: Anthony Chalmers
Session: Biology-guided combination cancer therapy
Resources:
Slides
Combining immunotherapy and kinase inhibition
Presenter: Anna Obenauf
Session: Biology-guided combination cancer therapy
Resources:
Slides
Webcast
Introduction and presentation of case/condition 1: TNBC
Presenter: Peter Dubsky
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Presentation of case/condition 2: HER2+ BC
Presenter: Frederik Marmé
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Webcast
Tailored surgical therapy after NACT
Presenter: Chin-Sheng Hung
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Webcast
Tailored radiotherapy after NACT
Presenter: Boon Chua
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Webcast
Tailored systemic therapy after NACT
Presenter: Frederik Marmé
Session: Tailoring local and systemic treatment after neoadjuvant chemotherapy (NACT): pCR versus non-pCR
Resources:
Slides
Webcast
Introduction and presentation of case/condition
Presenter: Peter Schmid
Session: Managing a challenging situation in metastatic breast cancer patients treated with immunotherapy
Resources:
Slides
The role of the pathologist in the optimal management of immunotherapeutics
Presenter: Anne Vincent-Salomon
Session: Managing a challenging situation in metastatic breast cancer patients treated with immunotherapy
Resources:
Slides
Webcast